We are delighted to share some highly viewed papers on cancer immunology and immunotherapy that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will interest you.

The list of relevant papers can be seen below:

“Dendritic Cells in Cancer Immunology and Immunotherapy”
by Laura Hato, Angel Vizcay, Iñaki Eguren, José L. Pérez-Gracia, Javier Rodríguez, Jaime Gállego Pérez-Larraya, Pablo Sarobe, Susana Inogés, Ascensión López Díaz de Cerio and Marta Santisteban
Cancers 2024, 16(5), 981; https://doi.org/10.3390/cancers16050981
Available online: https://www.mdpi.com/2072-6694/16/5/981

“Immunotherapeutic Strategies for the Treatment of Glioblastoma: Current Challenges and Future Perspectives”
by Ilaria Salvato and Antonio Marchini
Cancers 2024, 16(7), 1276; https://doi.org/10.3390/cancers16071276
Available online: https://www.mdpi.com/2072-6694/16/7/1276

“Advancing Esophageal Cancer Treatment: Immunotherapy in Neoadjuvant and Adjuvant Settings”
by Daniel Park, Won Jin Jeon, Chieh Yang and Dani Ran Castillo
Cancers 2024, 16(2), 318; https://doi.org/10.3390/cancers16020318
Available online: https://www.mdpi.com/2072-6694/16/2/318

“The JAK-STAT Pathway as a Therapeutic Strategy in Cancer Patients with Immune Checkpoint Inhibitor-Induced Colitis: A Narrative Review”
by Antonietta Gerarda Gravina, Raffaele Pellegrino, Alfonso Esposito, Marina Cipullo, Mario Romeo, Giovanna Palladino, Patrizia Iodice, Alessandro Federico and Teresa Troiani
Cancers 2024, 16(3), 611; https://doi.org/10.3390/cancers16030611
Available online: https://www.mdpi.com/2072-6694/16/3/611

“Triple Negative Breast Cancer: Molecular Subtype-Specific Immune Landscapes with Therapeutic Implications”
by Antonia Syrnioti, Stamatios Petousis, Lisa A. Newman, Chrysoula Margioula-Siarkou, Theodora Papamitsou, Konstantinos Dinas and Triantafyllia Koletsa
Cancers 2024, 16(11), 2094; https://doi.org/10.3390/cancers16112094
Available online: https://www.mdpi.com/2072-6694/16/11/2094

“Preclinical Evaluation of Novel Folate Receptor 1-Directed CAR T Cells for Ovarian Cancer”
by Julie Daigre, Manuel Martinez-Osuna, Maria Bethke, Larissa Steiner, Vera Dittmer, Katrin Krischer, Cathrin Bleilevens, Janina Brauner, Jens Kopatz, Matthias David Grundmann et al.
Cancers 2024, 16(2), 333; https://doi.org/10.3390/cancers16020333
Available online: https://www.mdpi.com/2072-6694/16/2/333

Special Issues:

“Oncolytic Viruses as an Emerging Aspect of Immune Oncology”
Guest Editor: Dr. Jennifer Altomonte
Submission deadline: 31 March 2025

“Immunotherapy with Checkpoint Inhibitors for Non-small Cell Lung Cancer”
Guest Editors: Dr. Alessandro Inno and Dr. Diego Signorelli
Submission deadline: 31 March 2025

“Evidence from the Real World Provides New Insights into the Evolving Landscape of Cancer Immunotherapy”
Guest Editors: Dr. Fabrizio Nelli, Dr. Carlo Signorelli, and Dr. Enzo Ruggeri
Submission deadline: 30 April 2025

“How to Properly Diagnose and Treat Immune-Related Adverse Events during Immunotherapy in Patients with Cancer: Discussion between Specialists”
Guest Editors: Dr. Angioletta Lasagna and Dr. Paolo Sacchi
Submission deadline: 30 April 2025

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office